FA Symposium 2023: Friedreich's Ataxia Treatment Pipeline-Clinical Stage Programs (Part 3 of 7)

FARA's Mission is to marshal and focus the resources and relationships needed to cure Friedreich's Ataxia (FA) by raising funds for research, promoting public awareness, and aligning scientists, patients, clinicians, government agencies, pharmaceutical companies and other organizations dedicated to curing FA and related diseases.
Friedreich’s Ataxia is a debilitating, life-shortening, degenerative neuro-muscular disorder. About one in 50,000 people in the United States have Friedreich's Ataxia.
Subscribe to FARA's KZbin channel / fara1998
Follow FARA on Facebook / curefa
Follow FARA on Instagram / curefa_org